Niacin: a powerful adjunct to other lipid-lowering drugs in reducing plaque progression and acute coronary events.
Davidson
Michael H
MH
Department of Preventive Cardiology, Rush-Presbyterian-St. Luke's Medical Center, 1725 West Harrison Street, Chicago, IL 60612, USA. michaeldavidson@radiantresearch.com
D000208:Acute Disease; D000465:Algorithms; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D003327:Coronary Disease / Q000150:complications / Q000188:drug therapy* / Q000517:prevention & control*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000378:metabolism; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009525:Niacin / Q000627:therapeutic use*
D000960:Hypolipidemic Agents; D009525:Niacin